PDIA3P has been found to regulate multiple myeloma cell growth and resistance to the drug bortezomib through its influence on the enzyme glucose 6-phosphate dehydrogenase (G6PD) and the pentose phosphate pathway.171. The gene discussed is G6PD; the disease is plasma cell myeloma.